The normally closely guarded world of drug pricing is getting a very public airing in a feud between two of the industry’s biggest companies. The attention drawn to the secret world of rebates could hurt the profits of some of the industry’s most successful drugs. Pfizer filed a lawsuit Wednesday claiming that rival Johnson & Johnson used anticompetitive marketing tactics to protect its blockbuster anti-inflammatory drug, Remicade, from Pfizer’s cheaper Inflectra, a so-called biosimilar version. ...
The normally closely guarded world of drug pricing is getting a very public airing in a feud between two of the industry’s biggest companies. The attention drawn to the secret world of rebates could hurt the profits of some of the industry’s most successful drugs.